Clinical Trial Update: Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated imatinib (Gleevec) in combination with weekly paclitaxel in patients aged 70 and older with advanced non-small cell lung cancer; the c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gleevec (Imatinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-07-03